SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Eloxx Pharmaceuticals, Inc. (ELOX) Reports $5.5M Q3 Net Loss; Cash Runway Into 2028

Eloxx reported a Q3 2026 net loss of $5.5M, versus $0.4M in Q3 2025, and cash of $56.3M at September 30, versus $62.0M at June 30. The company said cash is expected to fund operations into 2028.Material DetailsContext by AI AnalystThe results reflect an early-stage clinical company beginning Phase…

ELOX

Related stories